| 1 |
Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors.Clin Cancer Res. 2016 Jan 1;22(1):96-106. doi: 10.1158/1078-0432.CCR-15-0743. Epub 2015 Sep 15.
|
| 2 |
Copper-dependent ATP7B up-regulation drives the resistance of TMEM16A-overexpressing head-and-neck cancer models to platinum toxicity.Biochem J. 2019 Dec 19;476(24):3705-3719. doi: 10.1042/BCJ20190591.
|
| 3 |
Chemoradiotherapy-related carotid artery inflammation in head and neck cancer patients quantified by [(18)F]FDG PET/CT.Oral Oncol. 2019 Jun;93:101-106. doi: 10.1016/j.oraloncology.2019.04.008. Epub 2019 May 1.
|
| 4 |
Association of cytochrome P450 1B1 haplotypes with head and neck cancer risk.Environ Mol Mutagen. 2017 Jul;58(6):443-450. doi: 10.1002/em.22098. Epub 2017 May 28.
|
| 5 |
Functional and genomic analyses reveal therapeutic potential of targeting -catenin/CBP activity in head and neck cancer.Genome Med. 2018 Jul 20;10(1):54. doi: 10.1186/s13073-018-0569-7.
|
| 6 |
The atypical MAPK ERK3 potently suppresses melanoma cell growth and invasiveness.J Cell Physiol. 2019 Aug;234(8):13220-13232. doi: 10.1002/jcp.27994. Epub 2018 Dec 19.
|
| 7 |
Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones.BMC Cancer. 2016 Jul 4;16:382. doi: 10.1186/s12885-016-2430-y.
|
| 8 |
Reduced expression of DNA repair genes (XRCC1, XPD, and OGG1) in squamous cell carcinoma of head and neck in North India.Tumour Biol. 2012 Feb;33(1):111-9. doi: 10.1007/s13277-011-0253-7. Epub 2011 Nov 15.
|
| 9 |
The effects and safety of PD-1/PD-L1 inhibitors on head and neck cancer: A systematic review and meta-analysis.Cancer Med. 2019 Oct;8(13):5969-5978. doi: 10.1002/cam4.2510. Epub 2019 Aug 22.
|
| 10 |
Multiple Defects Sensitize p53-Deficient Head and Neck Cancer Cells to the WEE1 Kinase Inhibition.Mol Cancer Res. 2019 May;17(5):1115-1128. doi: 10.1158/1541-7786.MCR-18-0860. Epub 2019 Jan 24.
|
| 11 |
Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score-Weighted Analysis.Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):929-937. doi: 10.1016/j.ijrobp.2017.06.2456. Epub 2017 Jun 27.
|
| 12 |
Radio-sensitization of head and neck cancer cells by a combination of poly(I:C) and cisplatin through downregulation of survivin and c-IAP2.Cell Oncol (Dordr). 2019 Feb;42(1):29-40. doi: 10.1007/s13402-018-0403-7. Epub 2018 Sep 4.
|
| 13 |
CDH11 inhibits proliferation and invasion in head and neck cancer.J Oral Pathol Med. 2017 Feb;46(2):89-97. doi: 10.1111/jop.12471. Epub 2016 Jul 10.
|
| 14 |
DEK promotes HPV-positive and -negative head and neck cancer cell proliferation.Oncogene. 2015 Feb 12;34(7):868-77. doi: 10.1038/onc.2014.15. Epub 2014 Mar 10.
|
| 15 |
Association of genetic variability in enzymes metabolizing chemotherapeutic agents with treatment response in head and neck cancer cases.Asia Pac J Clin Oncol. 2017 Apr;13(2):e11-e20. doi: 10.1111/ajco.12446. Epub 2016 Jan 21.
|
| 16 |
Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.Pharmacogenomics J. 2020 Apr;20(2):350. doi: 10.1038/s41397-019-0073-5.
|
| 17 |
Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.J Hepatol. 2009 Jan;50(1):118-27. doi: 10.1016/j.jhep.2008.08.015. Epub 2008 Oct 12.
|
| 18 |
Roles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer.Oncotarget. 2019 Apr 30;10(32):3066-3083. doi: 10.18632/oncotarget.24684. eCollection 2019 Apr 30.
|
| 19 |
Cancer gene therapy utilizing interleukin-13 receptor alpha2 chain.Curr Gene Ther. 2005 Apr;5(2):213-23. doi: 10.2174/1566523053544227.
|
| 20 |
Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue.Oncotarget. 2016 Nov 15;7(46):76151-76158. doi: 10.18632/oncotarget.12691.
|
| 21 |
Cancer-associated fibroblasts promote cancer cell growth through a miR-7-RASSF2-PAR-4 axis in the tumor microenvironment.Oncotarget. 2017 Jan 3;8(1):1290-1303. doi: 10.18632/oncotarget.13609.
|
| 22 |
Genetic reprogramming of tumor cells by zinc finger transcription factors.Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11716-21. doi: 10.1073/pnas.0501162102. Epub 2005 Aug 4.
|
| 23 |
XPD, APE1, and MUTYH polymorphisms increase head and neck cancer risk: effect of gene-gene and gene-environment interactions.Tumour Biol. 2015 Sep;36(10):7569-79. doi: 10.1007/s13277-015-3472-5. Epub 2015 Apr 29.
|
| 24 |
Inhibition of Glucosylceramide Synthase Sensitizes Head and Neck Cancer to Cisplatin.Mol Cancer Ther. 2015 Aug;14(8):1907-15. doi: 10.1158/1535-7163.MCT-15-0171. Epub 2015 Jun 10.
|
| 25 |
ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth. Sci Rep. 2014 Nov 4;4:6899.
|
| 26 |
A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism.Acta Otorhinolaryngol Ital. 2012 Feb;32(1):1-11.
|
| 27 |
Validation of Alcohol Flushing Questionnaire to Identify ALDH2 Status in a Case-Control Study of Head and Neck Cancer.Alcohol Clin Exp Res. 2019 Jun;43(6):1225-1233. doi: 10.1111/acer.14049. Epub 2019 Apr 29.
|
| 28 |
Identification of novel heterozygous Apex 1 gene variant (Glu87Gln) in patients withhead and neck cancer of Indian origin.J Cell Biochem. 2018 Nov;119(11):8851-8861. doi: 10.1002/jcb.27138. Epub 2018 Aug 4.
|
| 29 |
BBC3 is down-regulated with increased tumor size independently of p53 expression in head and neck cancer.Cancer Biomark. 2012;11(5):197-208. doi: 10.3233/CBM-2012-00286.
|
| 30 |
CD317 Signature in Head and Neck Cancer Indicates Poor Prognosis.J Dent Res. 2018 Jul;97(7):787-794. doi: 10.1177/0022034518758604. Epub 2018 Feb 27.
|
| 31 |
Quantitative Imaging of the Hypoxia-Related Marker CAIX in Head and Neck Squamous Cell Carcinoma Xenograft Models.Mol Pharm. 2019 Feb 4;16(2):701-708. doi: 10.1021/acs.molpharmaceut.8b00950. Epub 2018 Dec 31.
|
| 32 |
Focal overexpression of CEACAM6 contributes to enhanced tumourigenesis in head and neck cancer via suppression of apoptosis.Mol Cancer. 2012 Sep 28;11:74. doi: 10.1186/1476-4598-11-74.
|
| 33 |
Incidence and outcomes of radiation-induced late cranial neuropathy in 10-year survivors of head and neck cancer.Oral Oncol. 2019 Aug;95:59-64. doi: 10.1016/j.oraloncology.2019.05.014. Epub 2019 Jun 8.
|
| 34 |
Identification of guanine nucleotide-binding protein -7 as an epigenetically silenced gene in head and neck cancer by gene expression profiling.Int J Oncol. 2013 Apr;42(4):1427-36. doi: 10.3892/ijo.2013.1808. Epub 2013 Feb 6.
|
| 35 |
Therapeutic Targeting of Protein Kinase CK2 Gene Expression in Feline Oral Squamous Cell Carcinoma: A Naturally Occurring Large-Animal Model of Head and Neck Cancer.Hum Gene Ther Clin Dev. 2017 Jun;28(2):80-86. doi: 10.1089/humc.2017.008. Epub 2017 Mar 23.
|
| 36 |
Evaluation of the cancer stem cell marker DCLK1 in patients with lymph node metastases of head and neck cancer.Pathol Res Pract. 2019 Dec;215(12):152698. doi: 10.1016/j.prp.2019.152698. Epub 2019 Oct 23.
|
| 37 |
DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis.Oncogene. 2007 Jan 18;26(3):467-76. doi: 10.1038/sj.onc.1209802. Epub 2006 Jul 31.
|
| 38 |
ECE-1 overexpression in head and neck cancer is associated with poor tumor differentiation and patient outcome.Oral Dis. 2019 Jan;25(1):44-53. doi: 10.1111/odi.12935. Epub 2018 Oct 21.
|
| 39 |
Correction to: Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: the NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobank.BMC Cancer. 2019 Oct 22;19(1):982. doi: 10.1186/s12885-019-6223-y.
|
| 40 |
MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer.Int J Cancer. 2019 Aug 1;145(3):748-762. doi: 10.1002/ijc.32170. Epub 2019 Feb 11.
|
| 41 |
FAT1 somatic mutations in head and neck carcinoma are associated with tumor progression and survival.Carcinogenesis. 2018 Dec 13;39(11):1320-1330. doi: 10.1093/carcin/bgy107.
|
| 42 |
Psychometric testing of the Fear of Cancer Recurrence Inventory-caregiver Chinese version in cancer family caregivers in Taiwan.Psychooncology. 2018 Jun;27(6):1580-1588. doi: 10.1002/pon.4697. Epub 2018 Mar 30.
|
| 43 |
The roles and mechanisms of G3BP1 in tumour promotion. J Drug Target. 2019 Mar;27(3):300-305.
|
| 44 |
Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis.Mol Carcinog. 2017 Mar;56(3):1107-1116. doi: 10.1002/mc.22577. Epub 2016 Nov 1.
|
| 45 |
DNA promoter hypermethylation contributes to down-regulation of galactocerebrosidase gene in lung and head and neck cancers.Int J Clin Exp Pathol. 2015 Sep 1;8(9):11042-50. eCollection 2015.
|
| 46 |
Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.Cancer. 2014 Jan 15;120(2):205-13. doi: 10.1002/cncr.28411. Epub 2013 Oct 10.
|
| 47 |
Loss of protein expression and recurrent DNA hypermethylation of the GNG7 gene in squamous cell carcinoma of the head and neck.J Appl Genet. 2012 May;53(2):167-74. doi: 10.1007/s13353-011-0079-4. Epub 2011 Dec 20.
|
| 48 |
GSTM3 A/B polymorphism and risk for head and neck cancer: a meta-analysis.PLoS One. 2014 Jan 8;9(1):e83851. doi: 10.1371/journal.pone.0083851. eCollection 2014.
|
| 49 |
Induction of heparanase by HPV E6 oncogene in head and neck squamous cell carcinoma.J Cell Mol Med. 2014 Jan;18(1):181-6. doi: 10.1111/jcmm.12179. Epub 2013 Nov 28.
|
| 50 |
Fibroblast gene expression profile reflects the stage of tumour progression in oral squamous cell carcinoma.J Pathol. 2011 Mar;223(4):459-69. doi: 10.1002/path.2841. Epub 2011 Jan 17.
|
| 51 |
Frequent aberrant expression of the human ether go-go (hEAG1) potassium channel in head and neck cancer: pathobiological mechanisms and clinical implications.J Mol Med (Berl). 2012 Oct;90(10):1173-84. doi: 10.1007/s00109-012-0893-0. Epub 2012 Mar 31.
|
| 52 |
Decreasing cytokeratin 17 expression in head and neck cancer predicts nodal metastasis and poor prognosis: The first evidence.Clin Otolaryngol. 2018 Aug;43(4):1010-1018. doi: 10.1111/coa.13092. Epub 2018 Apr 16.
|
| 53 |
Mechanisms responsible for signaling and functional defects.J Immunother. 1998 Jul;21(4):295-306. doi: 10.1097/00002371-199807000-00007.
|
| 54 |
Lymphotoxin- Interacts with Methylated EGFR to Mediate Acquired Resistance to Cetuximab in Head and Neck Cancer.Clin Cancer Res. 2017 Aug 1;23(15):4388-4401. doi: 10.1158/1078-0432.CCR-16-1955. Epub 2017 Feb 14.
|
| 55 |
Lymphotoxin- receptor-NIK signaling induces alternative RELB/NF-B2 activation to promote metastatic gene expression and cell migration in head and neck cancer.Mol Carcinog. 2019 Mar;58(3):411-425. doi: 10.1002/mc.22938. Epub 2018 Nov 28.
|
| 56 |
Expression of cancer testis antigens in head and neck squamous cell carcinomas.Head Neck. 2006 Jul;28(7):614-9. doi: 10.1002/hed.20380.
|
| 57 |
MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma.Oncogene. 2019 Nov;38(48):7329-7341. doi: 10.1038/s41388-019-0945-9. Epub 2019 Aug 15.
|
| 58 |
Responsiveness of the EAT-10 to Clinical Change in Head and Neck Cancer Patients with Dysphagia.Int J Speech Lang Pathol. 2020 Feb;22(1):78-85. doi: 10.1080/17549507.2019.1596312. Epub 2019 Apr 28.
|
| 59 |
MELK inhibition targets cancer stem cells through downregulation of SOX2 expression in head and neck cancer cells.Oncol Rep. 2019 Apr;41(4):2540-2548. doi: 10.3892/or.2019.6988. Epub 2019 Jan 30.
|
| 60 |
Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis.Neoplasia. 2009 Dec;11(12):1371-82. doi: 10.1593/neo.91326.
|
| 61 |
The NEDD8 conjugation pathway regulates p53 transcriptional activity and head and neck cancer cell sensitivity to ionizing radiation.Int J Oncol. 2012 Oct;41(4):1531-40. doi: 10.3892/ijo.2012.1584. Epub 2012 Aug 7.
|
| 62 |
Nod-like receptors in head and neck squamous cell carcinoma.Acta Otolaryngol. 2013 Dec;133(12):1333-44. doi: 10.3109/00016489.2013.831476. Epub 2013 Sep 23.
|
| 63 |
microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.Oncotarget. 2016 Feb 16;7(7):8223-39. doi: 10.18632/oncotarget.6972.
|
| 64 |
P2X7 receptor and NLRP3 inflammasome activation in head and neck cancer.Oncotarget. 2017 Jul 25;8(30):48972-48982. doi: 10.18632/oncotarget.16903.
|
| 65 |
PAK2-c-Myc-PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect.Cell Death Dis. 2018 Aug 1;9(8):825. doi: 10.1038/s41419-018-0887-0.
|
| 66 |
Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.Cancer Lett. 2016 Feb 1;371(1):20-9. doi: 10.1016/j.canlet.2015.11.023. Epub 2015 Nov 23.
|
| 67 |
A PI3K/AKT Scaffolding Protein, IQ Motif-Containing GTPase Associating Protein 1 (IQGAP1), Promotes Head and Neck Carcinogenesis.Clin Cancer Res. 2020 Jan 1;26(1):301-311. doi: 10.1158/1078-0432.CCR-19-1063. Epub 2019 Oct 9.
|
| 68 |
Role of protein kinase N2 (PKN2) in cigarette smoke-mediated oncogenic transformation of oral cells.J Cell Commun Signal. 2018 Dec;12(4):709-721. doi: 10.1007/s12079-017-0442-2. Epub 2018 Feb 26.
|
| 69 |
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer.Oral Dis. 2015 Mar;21(2):207-15. doi: 10.1111/odi.12244. Epub 2014 Apr 28.
|
| 70 |
FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis.J Cell Biochem. 2007 Jan 1;100(1):16-28. doi: 10.1002/jcb.20922.
|
| 71 |
Association of RAD 51 135 G/C, 172 G/T and XRCC3 Thr241Met gene polymorphisms with increased risk of head and neck cancer.Asian Pac J Cancer Prev. 2014;15(23):10457-62. doi: 10.7314/apjcp.2014.15.23.10457.
|
| 72 |
TNF- promotes c-REL/Np63 interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer.Cancer Res. 2011 Nov 1;71(21):6867-77. doi: 10.1158/0008-5472.CAN-11-2460. Epub 2011 Sep 20.
|
| 73 |
RRM1 gene expression evaluated in the liquid biopsy (blood cfRNA) as a non-invasive, predictive factor for radiotherapy-induced oral mucositis and potential prognostic biomarker in head and neck cancer patients.Cancer Biomark. 2018;22(4):657-667. doi: 10.3233/CBM-171082.
|
| 74 |
Relationship Between -2028 C/T SELP Gene Polymorphism, Concentration of Plasma P-Selectin and Risk of Malnutrition in Head and Neck Cancer Patients.Pathol Oncol Res. 2019 Apr;25(2):741-749. doi: 10.1007/s12253-018-00578-w. Epub 2019 Jan 8.
|
| 75 |
NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy.Acta Oncol. 2019 Oct;58(10):1410-1415. doi: 10.1080/0284186X.2019.1654129. Epub 2019 Aug 21.
|
| 76 |
Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer.Carcinogenesis. 2009 Jun;30(6):977-81. doi: 10.1093/carcin/bgp076. Epub 2009 Apr 3.
|
| 77 |
Trop2 inhibition suppresses the proliferation and invasion of laryngeal carcinoma cells via the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway.Mol Med Rep. 2015 Jul;12(1):865-70. doi: 10.3892/mmr.2015.3485. Epub 2015 Mar 13.
|
| 78 |
Assessment of DNA repair susceptibility genes identified by whole exome sequencing in head and neck cancer.DNA Repair (Amst). 2018 Jun-Jul;66-67:50-63. doi: 10.1016/j.dnarep.2018.04.005. Epub 2018 Apr 26.
|
| 79 |
Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals.Clin Cancer Res. 2018 Jan 1;24(1):62-72. doi: 10.1158/1078-0432.CCR-17-0357. Epub 2017 Oct 23.
|
| 80 |
Breast Cancer (18)F-ISO-1 Uptake as a Marker of Proliferation Status.J Nucl Med. 2020 May;61(5):665-670. doi: 10.2967/jnumed.119.232363. Epub 2019 Dec 13.
|
| 81 |
Data-driven Analysis of TRP Channels in Cancer: Linking Variation in Gene Expression to Clinical Significance.Cancer Genomics Proteomics. 2016 Jan-Feb;13(1):83-90.
|
| 82 |
Effects of Salivary Mg on Head and Neck Carcinoma via TRPM7.J Dent Res. 2019 Mar;98(3):304-312. doi: 10.1177/0022034518813359. Epub 2018 Dec 4.
|
| 83 |
Identification of stable housekeeping genes in response to ionizing radiation in cancer research.Sci Rep. 2017 Mar 6;7:43763. doi: 10.1038/srep43763.
|
| 84 |
Granulocyte colony-stimulating factor (G-CSF)-mediated signaling regulates type IV collagenase activity in head and neck cancer cells.Int J Cancer. 2001 Jul 1;93(1):42-6. doi: 10.1002/ijc.1297.
|
| 85 |
N-acetylgalactosamine-6-sulfatase (GALNS), Similar to Glycodelin, Is a Potential General Biomarker for Multiple Malignancies.Anticancer Res. 2019 Nov;39(11):6317-6324. doi: 10.21873/anticanres.13842.
|
| 86 |
Association between expression of glutathione-associated enzymes and response to platinum-based chemotherapy in head and neck cancer.Chem Biol Interact. 1998 Apr 24;111-112:187-98. doi: 10.1016/s0009-2797(97)00161-0.
|
| 87 |
L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo.J Nucl Med. 2007 Dec;48(12):2063-71. doi: 10.2967/jnumed.107.043620.
|
| 88 |
Clinical Management of Head and Neck Cancer Cases: Role of Pharmacogenetics of CYP2 and GSTs.Oncol Res Treat. 2016;39(4):221-6. doi: 10.1159/000444608. Epub 2016 Feb 26.
|
| 89 |
Investigating the Association between Alcohol and Risk of Head and Neck Cancer in Taiwan.Sci Rep. 2017 Aug 29;7(1):9701. doi: 10.1038/s41598-017-08802-4.
|
| 90 |
Hypermethylation of carcinogen metabolism genes, CYP1A1, CYP2A13 and GSTM1 genes in head and neck cancer. Oral Dis. 2010 Oct;16(7):668-73.
|
| 91 |
Systematic Review and Meta-Analysis of the Relationship between EPHX1 Polymorphisms and the Risk of Head and Neck Cancer.PLoS One. 2015 Apr 29;10(4):e0123347. doi: 10.1371/journal.pone.0123347. eCollection 2015.
|
| 92 |
Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review.Am J Epidemiol. 2004 Jan 1;159(1):1-16. doi: 10.1093/aje/kwh003.
|
| 93 |
Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in Northeast Indian population.Tumour Biol. 2015 Aug;36(8):5773-83. doi: 10.1007/s13277-015-3246-0. Epub 2015 Feb 28.
|
| 94 |
Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patients.Int J Cancer. 2013 Jun 1;132(11):2520-7. doi: 10.1002/ijc.27946. Epub 2012 Dec 14.
|
| 95 |
Investigation of radiosensitivity gene signatures in cancer cell lines.PLoS One. 2014 Jan 22;9(1):e86329. doi: 10.1371/journal.pone.0086329. eCollection 2014.
|
| 96 |
Association of CYP1A1 and CYP2D6 gene polymorphisms with head and neck cancer in Tunisian patients.Mol Biol Rep. 2014;41(4):2591-600. doi: 10.1007/s11033-014-3117-6. Epub 2014 Jan 22.
|
| 97 |
N-acetyltransferase 2 genetic variants confer the susceptibility to head and neck carcinoma: evidence from 23 case-control studies.Tumour Biol. 2014 Apr;35(4):3585-95. doi: 10.1007/s13277-013-1473-9. Epub 2013 Dec 13.
|
| 98 |
A case-control study investigating the role of sulfotransferase 1A1 polymorphism in head and neck cancer.J Cancer Res Clin Oncol. 2006 Jul;132(7):466-72. doi: 10.1007/s00432-006-0093-9. Epub 2006 Mar 31.
|
| 99 |
TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer.Mol Cancer. 2013 Dec 1;12(1):151. doi: 10.1186/1476-4598-12-151.
|
| 100 |
Combined effect of genetic polymorphisms in phase I and II biotransformation enzymes on head and neck cancer risk.Head Neck. 2013 Jun;35(6):858-67. doi: 10.1002/hed.23054. Epub 2012 Jun 19.
|
| 101 |
Homozygous deletions of UGT2B17 modifies effects of smoking on TP53-mutations and relapse of head and neck carcinoma.BMC Cancer. 2015 Mar 31;15:205. doi: 10.1186/s12885-015-1220-2.
|
| 102 |
let-7 Modulates Chromatin Configuration and Target Gene Repression through Regulation of the ARID3B Complex.Cell Rep. 2016 Jan 26;14(3):520-533. doi: 10.1016/j.celrep.2015.12.064. Epub 2016 Jan 14.
|
| 103 |
Eps8 expression is significantly lower in p16(+) head and neck squamous cell carcinomas (HNSCCs) compared with p16(-) HNSCCs.Hum Pathol. 2018 Feb;72:45-51. doi: 10.1016/j.humpath.2017.10.021. Epub 2017 Oct 28.
|
| 104 |
An Oncogenic Role for Four-Jointed Box 1 (FJX1) in Nasopharyngeal Carcinoma.Dis Markers. 2019 May 19;2019:3857853. doi: 10.1155/2019/3857853. eCollection 2019.
|
| 105 |
Survival of Head and Neck Cancer Cells Relies upon LZK Kinase-Mediated Stabilization of Mutant p53.Cancer Res. 2017 Sep 15;77(18):4961-4972. doi: 10.1158/0008-5472.CAN-17-0267. Epub 2017 Jul 31.
|
| 106 |
Association of polymorphisms and haplotypes of the NBN gene with laryngeal cancer and multiple primary tumors of the head and neck.Head Neck. 2012 Mar;34(3):376-83. doi: 10.1002/hed.21741. Epub 2011 Apr 5.
|
| 107 |
MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.Cancer Res. 2016 Aug 15;76(16):4872-86. doi: 10.1158/0008-5472.CAN-15-1664. Epub 2016 May 24.
|
| 108 |
Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growth.Mol Cancer Ther. 2008 Jun;7(6):1355-64. doi: 10.1158/1535-7163.MCT-08-0104. Epub 2008 Jun 4.
|
| 109 |
Reactive oxygen species and p21Waf1/Cip1 are both essential for p53-mediated senescence of head and neck cancer cells.Cell Death Dis. 2015 Mar 12;6(3):e1678. doi: 10.1038/cddis.2015.44.
|
| 110 |
A coding variant in TMC8 (EVER2) is associated with high risk HPV infection and head and neck cancer risk.PLoS One. 2015 Apr 8;10(4):e0123716. doi: 10.1371/journal.pone.0123716. eCollection 2015.
|
| 111 |
Deletion of 3p13-14 locus spanning FOXP1 to SHQ1 cooperates with PTEN loss in prostate oncogenesis.Nat Commun. 2017 Oct 20;8(1):1081. doi: 10.1038/s41467-017-01198-9.
|
| 112 |
Targeting acid ceramidase sensitises head and neck cancer to cisplatin.Eur J Cancer. 2016 Jan;52:163-72. doi: 10.1016/j.ejca.2015.10.056. Epub 2015 Dec 11.
|
| 113 |
Lack of germ line changes in KISS1 and KAI1 genes in sporadic head and neck cancer patients of Pakistani origin.Asian Pac J Cancer Prev. 2011;12(10):2767-71.
|
| 114 |
Expression of cyclin-dependent kinase 2-associated protein 1 confers an independent prognosticator in nasopharyngeal carcinoma: a cohort study.J Clin Pathol. 2012 Sep;65(9):795-801. doi: 10.1136/jclinpath-2012-200893. Epub 2012 Jul 12.
|
| 115 |
Analysis of gene coexpression network reveals prognostic significance of CNFN in patients with head and neck cancer.Oncol Rep. 2019 Apr;41(4):2168-2180. doi: 10.3892/or.2019.7019. Epub 2019 Feb 18.
|
| 116 |
Involvement of Fanconi anemia genes FANCD2 and FANCF in the molecular basis of drug resistance in leukemia.Mol Med Rep. 2015 Jun;11(6):4605-10. doi: 10.3892/mmr.2015.3288. Epub 2015 Jan 30.
|
| 117 |
Tumor-specific mutation and downregulation of ING5 detected in oral squamous cell carcinoma.Int J Cancer. 2010 Nov 1;127(9):2088-94. doi: 10.1002/ijc.25224.
|
| 118 |
Whole blood transcriptome correlates with treatment response in nasopharyngeal carcinoma.J Exp Clin Cancer Res. 2012 Sep 17;31(1):76. doi: 10.1186/1756-9966-31-76.
|
| 119 |
HPV status is associated with altered PIWI-interacting RNA expression pattern in head and neck cancer.Oral Oncol. 2016 Apr;55:43-48. doi: 10.1016/j.oraloncology.2016.01.012. Epub 2016 Feb 4.
|
| 120 |
Exosome-delivered TRPP2 siRNA inhibits the epithelial-mesenchymal transition of FaDu cells.Oncol Lett. 2019 Feb;17(2):1953-1961. doi: 10.3892/ol.2018.9752. Epub 2018 Nov 23.
|
| 121 |
Prognostic significance of P53 histochemistry and DNA histogram parameters in head and neck malignancies.Anticancer Res. 2000 Sep-Oct;20(5C):4031-7.
|
| 122 |
TTP mediates cisplatin-induced apoptosis of head and neck cancer cells by down-regulating the expression of Bcl-2.J Chemother. 2015 Jun;27(3):174-80. doi: 10.1179/1973947814Y.0000000234. Epub 2015 Jan 21.
|
| 123 |
Sox11 promotes head and neck cancer progression via the regulation of SDCCAG8.J Exp Clin Cancer Res. 2019 Mar 29;38(1):138. doi: 10.1186/s13046-019-1146-7.
|
| 124 |
A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion.Oncogene. 2012 Jun 7;31(23):2888-98. doi: 10.1038/onc.2011.460. Epub 2011 Oct 10.
|
| 125 |
Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer.Cancer Genet Cytogenet. 2007 Feb;173(1):31-7. doi: 10.1016/j.cancergencyto.2006.09.008.
|
| 126 |
ALKBH overexpression in head and neck cancer: potential target for novel anticancer therapy.Sci Rep. 2019 Sep 13;9(1):13249. doi: 10.1038/s41598-019-49550-x.
|
| 127 |
Synergistic effect of 15-lipoxygenase 2 and radiation in killing head-and-neck cancer.Cancer Gene Ther. 2008 May;15(5):323-30. doi: 10.1038/cgt.2008.9. Epub 2008 Feb 22.
|
| 128 |
Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer.J Craniomaxillofac Surg. 2018 Mar;46(3):492-497. doi: 10.1016/j.jcms.2017.12.014. Epub 2017 Dec 24.
|
| 129 |
Inhibition of epithelial-mesenchymal transition by cetuximab via the EGFR-GEP100-Arf6-AMAP1 pathway in head and neck cancer.Head Neck. 2017 Mar;39(3):476-485. doi: 10.1002/hed.24626. Epub 2016 Nov 23.
|
| 130 |
Increased PD-1(+) and TIM-3(+) TILs during Cetuximab Therapy Inversely Correlate with Response in Head and Neck Cancer Patients.Cancer Immunol Res. 2017 May;5(5):408-416. doi: 10.1158/2326-6066.CIR-16-0333. Epub 2017 Apr 13.
|
| 131 |
Prophylactic NS-21 maintains the skin moisture but does not reduce the severity of radiation dermatitis in patients with head and neck cancer: a randomized control trial.Radiat Oncol. 2019 May 30;14(1):90. doi: 10.1186/s13014-019-1302-4.
|
| 132 |
C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer.Oncogene. 2018 Oct;37(43):5780-5793. doi: 10.1038/s41388-018-0375-0. Epub 2018 Jun 21.
|
| 133 |
Phosphorylation of PI3K regulatory subunit p85 contributes to resistance against PI3K inhibitors in radioresistant head and neck cancer.Oral Oncol. 2018 Mar;78:56-63. doi: 10.1016/j.oraloncology.2018.01.014. Epub 2018 Feb 20.
|
| 134 |
CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer.Clin Oral Investig. 2017 Jun;21(5):1503-1508. doi: 10.1007/s00784-016-1911-3. Epub 2016 Jul 21.
|
| 135 |
Change in CD3-chain expression is an independent predictor of disease status in head and neck cancer patients.Int J Cancer. 2016 Jul 1;139(1):122-9. doi: 10.1002/ijc.30046. Epub 2016 Mar 8.
|
| 136 |
CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer.Cancer Lett. 2018 Sep 28;432:180-190. doi: 10.1016/j.canlet.2018.06.018. Epub 2018 Jun 18.
|
| 137 |
CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced-stage head and neck squamous cell carcinoma.Head Neck. 2016 Apr;38 Suppl 1:E1392-403. doi: 10.1002/hed.24232. Epub 2015 Oct 30.
|
| 138 |
Human papillomavirus seropositivity and risks of head and neck cancer.Int J Cancer. 2007 Feb 15;120(4):825-32. doi: 10.1002/ijc.22330.
|
| 139 |
Clinical Significance of CUB and Sushi Multiple Domains 1 Inactivation in Head and Neck Squamous Cell Carcinoma.Int J Mol Sci. 2018 Dec 12;19(12):3996. doi: 10.3390/ijms19123996.
|
| 140 |
Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer.Br J Cancer. 2009 Jul 7;101(1):139-44. doi: 10.1038/sj.bjc.6605121.
|
| 141 |
Human papillomavirus oncogenic E6 protein regulates human -defensin 3 (hBD3) expression via the tumor suppressor protein p53.Oncotarget. 2016 May 10;7(19):27430-44. doi: 10.18632/oncotarget.8443.
|
| 142 |
Pseudolaric Acid B Induces Growth Inhibition and Caspase-Dependent Apoptosis on Head and Neck Cancer Cell lines through Death Receptor 5.Molecules. 2019 Oct 16;24(20):3715. doi: 10.3390/molecules24203715.
|
| 143 |
Systematic analysis of survival-associated alternative splicing signatures uncovers prognostic predictors for head and neck cancer.J Cell Physiol. 2019 Sep;234(9):15836-15846. doi: 10.1002/jcp.28241. Epub 2019 Feb 10.
|
| 144 |
Inactivation of the putative suppressor gene DOK1 by promoter hypermethylation in primary human cancers.Int J Cancer. 2012 Jun 1;130(11):2484-94. doi: 10.1002/ijc.26299. Epub 2011 Sep 22.
|
| 145 |
A Novel Polyphenol Conjugate Sensitizes Cisplatin-Resistant Head and Neck Cancer Cells to Cisplatin via Nrf2 Inhibition.Mol Cancer Ther. 2016 Nov;15(11):2620-2629. doi: 10.1158/1535-7163.MCT-16-0332. Epub 2016 Aug 22.
|
| 146 |
Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1): a target for cancer therapeutic intervention?.Cancer Cell Int. 2019 Aug 31;19:224. doi: 10.1186/s12935-019-0947-2. eCollection 2019.
|
| 147 |
The role of eukaryotic translation initiation factor 6 in tumors.Oncol Lett. 2017 Jul;14(1):3-9. doi: 10.3892/ol.2017.6161. Epub 2017 May 12.
|
| 148 |
Single-nucleotide polymorphisms in nucleotide excision repair genes, cigarette smoking, and the risk of head and neck cancer.Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1428-45. doi: 10.1158/1055-9965.EPI-13-0185. Epub 2013 May 29.
|
| 149 |
Functional analysis of ESM1 by siRNA knockdown in primary and metastatic head and neck cancer cells.J Oral Pathol Med. 2018 Jan;47(1):40-47. doi: 10.1111/jop.12648. Epub 2017 Oct 30.
|
| 150 |
Volatilomic insight of head and neck cancer via the effects observed on saliva metabolites.Sci Rep. 2018 Dec 7;8(1):17725. doi: 10.1038/s41598-018-35854-x.
|
| 151 |
Hypomethylated Fgf3 is a potential biomarker for early detection of oral cancer in mice treated with the tobacco carcinogen dibenzo[def,p]chrysene.PLoS One. 2017 Oct 26;12(10):e0186873. doi: 10.1371/journal.pone.0186873. eCollection 2017.
|
| 152 |
The interplay between alcohol consumption, oral hygiene, ALDH2 and ADH1B in the risk of head and neck cancer.Int J Cancer. 2014 Nov 15;135(10):2424-36. doi: 10.1002/ijc.28885. Epub 2014 Apr 19.
|
| 153 |
Golgi integral membrane protein 4 manipulates cellular proliferation, apoptosis, and cell cycle in human head and neck cancer.Biosci Rep. 2018 Aug 31;38(4):BSR20180454. doi: 10.1042/BSR20180454. Print 2018 Aug 31.
|
| 154 |
The Proton-Sensing G-Protein Coupled Receptor GPR4 Promotes Angiogenesis in Head and Neck Cancer.PLoS One. 2016 Apr 14;11(4):e0152789. doi: 10.1371/journal.pone.0152789. eCollection 2016.
|
| 155 |
Meta-analysis of glutathione S-transferase M1 genotype and risk toward head and neck cancer.Head Neck. 2006 Mar;28(3):217-24. doi: 10.1002/hed.20295.
|
| 156 |
TIM-3 expression and its association with overall survival in primary osteosarcoma.Oncol Lett. 2019 Nov;18(5):5294-5300. doi: 10.3892/ol.2019.10855. Epub 2019 Sep 12.
|
| 157 |
HOPX functions as a tumour suppressor in head and neck cancer.Sci Rep. 2016 Dec 9;6:38758. doi: 10.1038/srep38758.
|
| 158 |
POU2F1 activity regulates HOXD10 and HOXD11 promoting a proliferative and invasive phenotype in head and neck cancer.Oncotarget. 2014 Sep 30;5(18):8803-15. doi: 10.18632/oncotarget.2492.
|
| 159 |
Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity.J Biol Chem. 2010 Sep 3;285(36):28010-9. doi: 10.1074/jbc.M110.116384. Epub 2010 Jun 24.
|
| 160 |
Lin28b promotes head and neck cancer progression via modulation of the insulin-like growth factor survival pathway.Oncotarget. 2012 Dec;3(12):1641-52. doi: 10.18632/oncotarget.785.
|
| 161 |
Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.Gene. 2005 Aug 15;356:109-17. doi: 10.1016/j.gene.2005.02.014.
|
| 162 |
Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5.Genome Biol. 2019 Jan 14;20(1):12. doi: 10.1186/s13059-018-1604-0.
|
| 163 |
Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer.Cancer Sci. 2017 Aug;108(8):1681-1692. doi: 10.1111/cas.13298. Epub 2017 Jul 4.
|
| 164 |
Use of telomelysin (OBP-301) in mouse xenografts of human head and neck cancer.Oncol Rep. 2009 Nov;22(5):1039-43. doi: 10.3892/or_00000533.
|
| 165 |
Events of alternative splicing in head and neck cancer via RNA sequencing - an update.BMC Genomics. 2019 Jun 3;20(1):442. doi: 10.1186/s12864-019-5794-y.
|
| 166 |
LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling.Oncogene. 2014 Mar 13;33(11):1375-84. doi: 10.1038/onc.2013.98. Epub 2013 Apr 29.
|
| 167 |
Reliability and psychometric validity of Hindi version of Depression, Anxiety and Stress Scale-21 (DASS-21) for Hindi speaking Head Neck Cancer and Oral Potentially Malignant Disorders Patients.J Cancer Res Ther. 2019 Jul-Sep;15(3):653-658. doi: 10.4103/jcrt.JCRT_281_17.
|
| 168 |
T-lymphocyte maturation-associated protein gene as a candidate metastasis suppressor for head and neck squamous cell carcinomas.Cancer Sci. 2009 May;100(5):873-80. doi: 10.1111/j.1349-7006.2009.01132.x.
|
| 169 |
Automatic replanning of VMAT plans for different treatment machines: Atemplate-based approach using constrained optimization.Strahlenther Onkol. 2018 Oct;194(10):921-928. doi: 10.1007/s00066-018-1319-x. Epub 2018 May 30.
|
| 170 |
MTA3-SOX2 Module Regulates Cancer Stemness and Contributes to Clinical Outcomes of Tongue Carcinoma.Front Oncol. 2019 Aug 27;9:816. doi: 10.3389/fonc.2019.00816. eCollection 2019.
|
| 171 |
Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence.Mol Cancer Ther. 2015 Feb;14(2):608-19. doi: 10.1158/1535-7163.MCT-14-0735-T. Epub 2014 Dec 10.
|
| 172 |
HSPA5 negatively regulates lysosomal activity through ubiquitination of MUL1 in head and neck cancer.Autophagy. 2018;14(3):385-403. doi: 10.1080/15548627.2017.1414126. Epub 2018 Feb 21.
|
| 173 |
Regulation and function of Myb-binding protein 1A (MYBBP1A) in cellular senescence and pathogenesis of head and neck cancer.Cancer Lett. 2015 Mar 28;358(2):191-199. doi: 10.1016/j.canlet.2014.12.042. Epub 2014 Dec 24.
|
| 174 |
High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-status.Oncotarget. 2016 Apr 5;7(14):18665-77. doi: 10.18632/oncotarget.7625.
|
| 175 |
Quantitative proteomics unveiled: Regulation of DNA double strand break repair by EGFR involves PARP1.Radiother Oncol. 2015 Sep;116(3):423-30. doi: 10.1016/j.radonc.2015.09.018. Epub 2015 Sep 25.
|
| 176 |
Mutations and polymorphisms in mitochondrial DNA in head and neck cancer cell lines.Acta Otorhinolaryngol Ital. 2006 Aug;26(4):185-90.
|
| 177 |
Molecular disruption of NBS1 with targeted gene delivery enhances chemosensitisation in head and neck cancer.Br J Cancer. 2010 Dec 7;103(12):1822-30. doi: 10.1038/sj.bjc.6605980. Epub 2010 Nov 9.
|
| 178 |
Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer.Oncol Rep. 2014 Feb;31(2):1014-20. doi: 10.3892/or.2013.2927. Epub 2013 Dec 16.
|
| 179 |
WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer.Sci Rep. 2017 Jan 19;7:40664. doi: 10.1038/srep40664.
|
| 180 |
Vascular endothelial growth factor-A and Poly(A) binding protein-interacting protein 2 expression in human head and neck carcinomas: correlation and prognostic significance.Br J Cancer. 2006 May 22;94(10):1516-23. doi: 10.1038/sj.bjc.6603108.
|
| 181 |
Genome-wide association study identifies genes associated with neuropathy in patients with head and neck cancer.Sci Rep. 2018 Jun 8;8(1):8789. doi: 10.1038/s41598-018-27070-4.
|
| 182 |
Profilin 2 Promotes Proliferation and Metastasis of Head and Neck Cancer Cells by Regulating PI3K/AKT/-Catenin Signaling Pathway.Oncol Res. 2019 Sep 23;27(9):1079-1088. doi: 10.3727/096504019X15579146061957. Epub 2019 May 15.
|
| 183 |
Monte Carlo radiotherapy simulations of accelerated repopulation and reoxygenation for hypoxic head and neck cancer.Br J Radiol. 2011 Oct;84(1006):903-18. doi: 10.1259/bjr/25012212.
|
| 184 |
Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitors.Cancer Gene Ther. 2013 Oct;20(10):582-9. doi: 10.1038/cgt.2013.55. Epub 2013 Sep 13.
|
| 185 |
Posttraumatic growth in head and neck cancer survivors: Is it possible and what are the correlates?.Psychooncology. 2018 Jun;27(6):1517-1523. doi: 10.1002/pon.4682. Epub 2018 Apr 16.
|
| 186 |
The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers.Oncotarget. 2017 Jan 17;8(3):4501-4519. doi: 10.18632/oncotarget.13885.
|
| 187 |
Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer.Oncogene. 2016 Mar 3;35(9):1163-9. doi: 10.1038/onc.2015.171. Epub 2015 May 18.
|
| 188 |
PTTG and PBF Functionally Interact with p53 and Predict Overall Survival in Head and Neck Cancer.Cancer Res. 2018 Oct 15;78(20):5863-5876. doi: 10.1158/0008-5472.CAN-18-0855. Epub 2018 Aug 28.
|
| 189 |
Rab25 regulates invasion and metastasis in head and neck cancer.Clin Cancer Res. 2013 Mar 15;19(6):1375-88. doi: 10.1158/1078-0432.CCR-12-2858. Epub 2013 Jan 22.
|
| 190 |
Downregulation of RAD17 in head and neck cancer.Head Neck. 2008 Jan;30(1):35-42. doi: 10.1002/hed.20660.
|
| 191 |
The MRN protein complex genes: MRE11 and RAD50 and susceptibility to head and neck cancers.Mol Cancer. 2013 Sep 30;12(1):113. doi: 10.1186/1476-4598-12-113.
|
| 192 |
Rad51C: a novel suppressor gene modulates the risk of head and neck cancer.Mutat Res. 2014 Apr;762:47-54. doi: 10.1016/j.mrfmmm.2014.02.007. Epub 2014 Mar 12.
|
| 193 |
The RARS-MAD1L1 Fusion Gene Induces Cancer Stem Cell-like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma. Clin Cancer Res. 2018 Feb 1;24(3):659-673.
|
| 194 |
Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.BMC Cancer. 2016 Feb 29;16:170. doi: 10.1186/s12885-016-2209-1.
|
| 195 |
Pocket proteins suppress head and neck cancer.Cancer Res. 2012 Mar 1;72(5):1280-9. doi: 10.1158/0008-5472.CAN-11-2833. Epub 2012 Jan 11.
|
| 196 |
Disruption of KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex components by multiple genetic mechanisms: Association with poor prognosis in head and neck cancer.Head Neck. 2015 May;37(5):727-34. doi: 10.1002/hed.23663. Epub 2014 Jun 18.
|
| 197 |
Expression of REG III and prognosis in head and neck cancer.Oncol Rep. 2013 Aug;30(2):573-8. doi: 10.3892/or.2013.2521. Epub 2013 Jun 5.
|
| 198 |
Genetic variation of fifteen folate metabolic pathway associated gene loci and the risk of incident head and neck carcinoma: the Women's Genome Health Study.Clin Chim Acta. 2013 Mar 15;418:33-6. doi: 10.1016/j.cca.2012.11.030. Epub 2012 Dec 28.
|
| 199 |
Identification of a candidate tumor suppressor gene RHOBTB1 located at a novel allelic loss region 10q21 in head and neck cancer.J Cancer Res Clin Oncol. 2006 Jan;132(1):19-27. doi: 10.1007/s00432-005-0033-0. Epub 2005 Sep 17.
|
| 200 |
RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems.Redox Biol. 2017 Oct;13:219-227. doi: 10.1016/j.redox.2017.05.025. Epub 2017 Jun 1.
|
| 201 |
Investigation of the association of hRRM1 and p53R2 gene polymorphisms in head and neck squamous cell carcinomas.Med Oncol. 2014 Jul;31(7):12. doi: 10.1007/s12032-014-0012-x. Epub 2014 May 27.
|
| 202 |
Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.Int J Cancer. 2019 Dec 15;145(12):3299-3310. doi: 10.1002/ijc.32481. Epub 2019 Jun 19.
|
| 203 |
Down-regulation of S100A2 in lymph node metastases of head and neck cancer.Head Neck. 2007 Mar;29(3):236-43. doi: 10.1002/hed.20511.
|
| 204 |
Nuclear S100A7 is associated with poor prognosis in head and neck cancer.PLoS One. 2010 Aug 3;5(8):e11939. doi: 10.1371/journal.pone.0011939.
|
| 205 |
Plasminogen activator inhibitor-1 as regulator of tumor-initiating cell properties in head and neck cancers.Head Neck. 2016 Apr;38 Suppl 1:E895-904. doi: 10.1002/hed.24124. Epub 2015 Jul 16.
|
| 206 |
Suppression of SESN1 reduces cisplatin and hyperthermia resistance through increasing reactive oxygen species (ROS) in human maxillary cancer cells.Int J Hyperthermia. 2018 Dec;35(1):269-278. doi: 10.1080/02656736.2018.1496282. Epub 2018 Oct 9.
|
| 207 |
Knockdown of SET Domain, Bifurcated 1 suppresses head and neck cancer cell viability and wound-healing ability in vitro.Turk J Biol. 2019 Oct 14;43(5):281-292. doi: 10.3906/biy-1903-71. eCollection 2019.
|
| 208 |
DNMT3B C46359T and SHMT1 C1420T polymorphisms in the folate pathway in carcinogenesis of head and neck.Mol Biol Rep. 2014 Feb;41(2):581-9. doi: 10.1007/s11033-013-2895-6. Epub 2013 Dec 22.
|
| 209 |
Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers.Cancer Med. 2014 Apr;3(2):426-33. doi: 10.1002/cam4.201. Epub 2014 Feb 12.
|
| 210 |
Voxel based comparison and texture analysis of 18F-FDG and 18F-FMISO PET of patients with head-and-neck cancer.PLoS One. 2019 Feb 28;14(2):e0213111. doi: 10.1371/journal.pone.0213111. eCollection 2019.
|
| 211 |
The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial-like head and neck carcinoma subtypes.Head Neck. 2019 Jun;41(6):1830-1845. doi: 10.1002/hed.25623. Epub 2019 Jan 16.
|
| 212 |
Carboxy-terminus Hsc70 interacting protein exerts a tumor inhibition function in head and neck cancer.Oncol Rep. 2017 Sep;38(3):1629-1636. doi: 10.3892/or.2017.5827. Epub 2017 Jul 17.
|
| 213 |
Cancer stem-like cell related protein CD166 degrades through E3 ubiquitin ligase CHIP in head and neck cancer.Exp Cell Res. 2017 Apr 1;353(1):46-53. doi: 10.1016/j.yexcr.2017.03.005. Epub 2017 Mar 6.
|
| 214 |
Variation in the gene TAS2R13 is associated with differences in alcohol consumption in patients with head and neck cancer.Chem Senses. 2012 Oct;37(8):737-44. doi: 10.1093/chemse/bjs063. Epub 2012 Jul 23.
|
| 215 |
Effects of chemotherapy on gene expression of lingual taste receptors in patients with head and neck cancer.Laryngoscope. 2016 Mar;126(3):E103-9. doi: 10.1002/lary.25679. Epub 2015 Sep 30.
|
| 216 |
Analysis of the TAX1BP1 gene in head and neck cancer patients.Braz J Otorhinolaryngol. 2010 Mar-Apr;76(2):193-8. doi: 10.1590/S1808-86942010000200008.
|
| 217 |
4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer.Cancer Res. 2019 Apr 1;79(7):1438-1450. doi: 10.1158/0008-5472.CAN-18-1220. Epub 2019 Mar 20.
|
| 218 |
Association of TET3 epigenetic inactivation with head and neck cancer.Oncotarget. 2018 May 11;9(36):24480-24493. doi: 10.18632/oncotarget.25333. eCollection 2018 May 11.
|
| 219 |
A functional TNFAIP2 3'-UTR rs8126 genetic polymorphism contributes to risk of esophageal squamous cell carcinoma.PLoS One. 2014 Nov 10;9(11):e109318. doi: 10.1371/journal.pone.0109318. eCollection 2014.
|
| 220 |
Interaction between N-cadherin and decoy receptor-2 regulates apoptosis in head and neck cancer.Oncotarget. 2018 Jul 31;9(59):31516-31530. doi: 10.18632/oncotarget.25846. eCollection 2018 Jul 31.
|
| 221 |
Differential regulation of NF-kB and IRF target genes as they relate to fatigue in patients with head and neck cancer.Brain Behav Immun. 2018 Nov;74:291-295. doi: 10.1016/j.bbi.2018.09.013. Epub 2018 Sep 11.
|
| 222 |
TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer.Nat Commun. 2014 Jul 31;5:4527. doi: 10.1038/ncomms5527.
|
| 223 |
The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.Tumour Biol. 2015 Dec;36(12):9487-97. doi: 10.1007/s13277-015-3618-5. Epub 2015 Jul 1.
|
| 224 |
Delineation and candidate gene mutation screening of the 18q22 minimal region of deletion in head and neck squamous cell carcinoma.Oncogene. 2002 Jul 25;21(32):5016-23. doi: 10.1038/sj.onc.1205626.
|
| 225 |
Identification of two new members of the CSMD gene family.Genomics. 2003 Sep;82(3):412-5. doi: 10.1016/s0888-7543(03)00149-6.
|
| 226 |
Could excision repair cross-complementing group-1 mRNA expression from peripheral blood lymphocytes predict locoregional failure with cisplatin chemoradiation for locally advanced laryngeal cancer?.Asia Pac J Clin Oncol. 2020 Apr;16(2):e19-e26. doi: 10.1111/ajco.13239. Epub 2019 Oct 15.
|
| 227 |
Ad5CMVp53 gene therapy for locally advanced prostate cancer--where do we stand?.World J Urol. 2000 Apr;18(2):121-4. doi: 10.1007/s003450050183.
|
| 228 |
Functional and T cell receptor gene usage analysis of cytotoxic T lymphocytes in fresh tumor-infiltrating lymphocytes from human head and neck cancer.Jpn J Cancer Res. 1995 May;86(5):477-83. doi: 10.1111/j.1349-7006.1995.tb03081.x.
|
| 229 |
PRK, a cell cycle gene localized to 8p21, is downregulated in head and neck cancer.Genes Chromosomes Cancer. 2000 Mar;27(3):332-6. doi: 10.1002/(sici)1098-2264(200003)27:3<332::aid-gcc15>3.0.co;2-k.
|
|
|
|
|
|
|
